Your browser doesn't support javascript.
loading
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
Yamazaki, K; Nagase, M; Tamagawa, H; Ueda, S; Tamura, T; Murata, K; Eguchi Nakajima, T; Baba, E; Tsuda, M; Moriwaki, T; Esaki, T; Tsuji, Y; Muro, K; Taira, K; Denda, T; Funai, S; Shinozaki, K; Yamashita, H; Sugimoto, N; Okuno, T; Nishina, T; Umeki, M; Kurimoto, T; Takayama, T; Tsuji, A; Yoshida, M; Hosokawa, A; Shibata, Y; Suyama, K; Okabe, M; Suzuki, K; Seki, N; Kawakami, K; Sato, M; Fujikawa, K; Hirashima, T; Shimura, T; Taku, K; Otsuji, T; Tamura, F; Shinozaki, E; Nakashima, K; Hara, H; Tsushima, T; Ando, M; Morita, S; Boku, N; Hyodo, I.
Afiliação
  • Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka k.yamazaki@scchr.jp.
  • Nagase M; Department of Clinical Oncology, Jichi Medical University, Shimotsuke.
  • Tamagawa H; Department of Surgery, Osaka General Medical Center, Osaka.
  • Ueda S; Department of Medical Oncology, Kinki University Faculty of Medicine, Higashiosaka.
  • Tamura T; Department of Medical Oncology, Nara Hospital Kinki University Faculty of Medicine, Ikoma.
  • Murata K; Department of Surgery, Suita Municipal Hospital, Suita.
  • Eguchi Nakajima T; Department of Clinical Oncology, St Marianna University School of Medicine, Kawasaki.
  • Baba E; Department of Comprehensive Clinical Oncology, Kyushu University Faculty of Medical Sciences, Fukuoka.
  • Tsuda M; Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi.
  • Moriwaki T; Division of Gastroenterology, University of Tsukuba, Tsukuba.
  • Esaki T; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka.
  • Tsuji Y; Department of Medical Oncology, Tonan Hospital, Sapporo.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya.
  • Taira K; Clinical Oncology, Osaka City General Hospital, Osaka.
  • Denda T; Division of Gastroenterology, Chiba Cancer Center, Chiba.
  • Funai S; Department of Surgery, Sakai Hospital Kinki University Faculty of Medicine, Sakai.
  • Shinozaki K; Division of Clinical Oncology, Hiroshima Prefectural Hospital, Hiroshima.
  • Yamashita H; Department of Gastroenterology and Hepatology, Okayama Medical Center, Okayama.
  • Sugimoto N; Department of Clinical Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka.
  • Okuno T; Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe.
  • Nishina T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matuyama.
  • Umeki M; Department of Surgery, Hyogo Prefectural Awaji Medical Center, Sumoto.
  • Kurimoto T; Department of Gastrointestinal Oncology, Nagoya Kyoritsu Hospital, Nagoya.
  • Takayama T; Department of Gastroenterology and Oncology, Tokushima University Graduate School, Tokushima.
  • Tsuji A; Department of Medical Oncology, Kochi Health Sciences Center, Kochi.
  • Yoshida M; Division of Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki.
  • Hosokawa A; Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, Toyama.
  • Shibata Y; Department of Chemotherapy, Miyazaki Prefectural Miyazaki Hospital, Miyazaki.
  • Suyama K; Department of Medical Oncology, Toranomon Hospital, Tokyo.
  • Okabe M; Department of Surgery, Kurashiki Central Hospital, Kurashiki.
  • Suzuki K; Department of gastroenterology, Kushiro City General Hospital, Kushiro.
  • Seki N; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo.
  • Kawakami K; Department of Gastroenterology, Muroran City General Hospital, Muroran.
  • Sato M; Department of Gastroenterology and Hepatology, Ryuugasaki Saiseikai Hospital, Ryugasaki.
  • Fujikawa K; Department of Gastroenterology, Hokkaido Cancer Center, Sapporo.
  • Hirashima T; Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino.
  • Shimura T; Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya.
  • Taku K; Division of Medical Oncology, Shizuoka General Hospital, Shizuoka.
  • Otsuji T; Department of Gastroenterology, Dongo Hospital, Yamatotakada.
  • Tamura F; Department of Gastroenterology, Kumamoto Regional Medical Center, Kumamoto.
  • Shinozaki E; Department of Gastroenterology, Cancer Institute Hospital of JFCR, Tokyo.
  • Nakashima K; First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki.
  • Hara H; Department of Gastroenterology, Saitama Cancer Center, Saitama.
  • Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka.
  • Ando M; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Boku N; Department of Clinical Oncology, St Marianna University School of Medicine, Kawasaki.
  • Hyodo I; Division of Gastroenterology, University of Tsukuba, Tsukuba.
Ann Oncol ; 27(8): 1539-46, 2016 08.
Article em En | MEDLINE | ID: mdl-27177863
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies País/Região como assunto: Asia Idioma: En Revista: Ann Oncol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab Tipo de estudo: Clinical_trials / Prognostic_studies País/Região como assunto: Asia Idioma: En Revista: Ann Oncol Ano de publicação: 2016 Tipo de documento: Article